nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—SLCO2B1—Tolbutamide—type 2 diabetes mellitus	0.386	0.574	CbGbCtD
Latanoprost—SLCO2B1—Glyburide—type 2 diabetes mellitus	0.221	0.33	CbGbCtD
Latanoprost—SLC22A1—Metformin—type 2 diabetes mellitus	0.0649	0.0966	CbGbCtD
Latanoprost—Iloprost—PLAT—type 2 diabetes mellitus	0.00435	0.838	CrCbGaD
Latanoprost—Tafluprost—PTGS2—type 2 diabetes mellitus	0.000843	0.162	CrCbGaD
Latanoprost—Bronchitis—Gliclazide—type 2 diabetes mellitus	0.000772	0.00373	CcSEcCtD
Latanoprost—Connective tissue disorder—Bromocriptine—type 2 diabetes mellitus	0.00077	0.00371	CcSEcCtD
Latanoprost—Rash—Miglitol—type 2 diabetes mellitus	0.000768	0.0037	CcSEcCtD
Latanoprost—Dermatitis—Miglitol—type 2 diabetes mellitus	0.000767	0.0037	CcSEcCtD
Latanoprost—Vision blurred—Glipizide—type 2 diabetes mellitus	0.000763	0.00368	CcSEcCtD
Latanoprost—Erythema—Glimepiride—type 2 diabetes mellitus	0.000756	0.00365	CcSEcCtD
Latanoprost—Oedema—Rosiglitazone—type 2 diabetes mellitus	0.000755	0.00364	CcSEcCtD
Latanoprost—Back pain—Pioglitazone—type 2 diabetes mellitus	0.00075	0.00362	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Gliclazide—type 2 diabetes mellitus	0.000746	0.0036	CcSEcCtD
Latanoprost—Nervous system disorder—Rosiglitazone—type 2 diabetes mellitus	0.00074	0.00357	CcSEcCtD
Latanoprost—Asthma—Orlistat—type 2 diabetes mellitus	0.000729	0.00352	CcSEcCtD
Latanoprost—Back pain—Sitagliptin—type 2 diabetes mellitus	0.000729	0.00351	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Repaglinide—type 2 diabetes mellitus	0.000728	0.00351	CcSEcCtD
Latanoprost—Vision blurred—Glimepiride—type 2 diabetes mellitus	0.000712	0.00344	CcSEcCtD
Latanoprost—Vision blurred—Sitagliptin—type 2 diabetes mellitus	0.00071	0.00342	CcSEcCtD
Latanoprost—Bronchitis—Valsartan—type 2 diabetes mellitus	0.00071	0.00342	CcSEcCtD
Latanoprost—Mediastinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000706	0.0034	CcSEcCtD
Latanoprost—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000705	0.0034	CcSEcCtD
Latanoprost—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000705	0.0034	CcSEcCtD
Latanoprost—Conjunctivitis—Gliclazide—type 2 diabetes mellitus	0.000696	0.00336	CcSEcCtD
Latanoprost—Urinary tract infection—Gliclazide—type 2 diabetes mellitus	0.000696	0.00336	CcSEcCtD
Latanoprost—Rash—Tolbutamide—type 2 diabetes mellitus	0.00069	0.00333	CcSEcCtD
Latanoprost—Arthralgia—Glipizide—type 2 diabetes mellitus	0.000689	0.00333	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Rosiglitazone—type 2 diabetes mellitus	0.000688	0.00332	CcSEcCtD
Latanoprost—Headache—Tolbutamide—type 2 diabetes mellitus	0.000686	0.00331	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Valsartan—type 2 diabetes mellitus	0.000686	0.00331	CcSEcCtD
Latanoprost—Discomfort—Glipizide—type 2 diabetes mellitus	0.000681	0.00329	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Orlistat—type 2 diabetes mellitus	0.000678	0.00327	CcSEcCtD
Latanoprost—Oedema—Glipizide—type 2 diabetes mellitus	0.000661	0.00319	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Irbesartan—type 2 diabetes mellitus	0.000661	0.00319	CcSEcCtD
Latanoprost—Chest pain—Pioglitazone—type 2 diabetes mellitus	0.00066	0.00319	CcSEcCtD
Latanoprost—Arthralgia—Pioglitazone—type 2 diabetes mellitus	0.00066	0.00319	CcSEcCtD
Latanoprost—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000659	0.00318	CcSEcCtD
Latanoprost—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000659	0.00318	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.000656	0.00316	CcSEcCtD
Latanoprost—Angina pectoris—Metformin—type 2 diabetes mellitus	0.000655	0.00316	CcSEcCtD
Latanoprost—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000653	0.00315	CcSEcCtD
Latanoprost—Discomfort—Pioglitazone—type 2 diabetes mellitus	0.000653	0.00315	CcSEcCtD
Latanoprost—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.000642	0.0031	CcSEcCtD
Latanoprost—Arthralgia—Sitagliptin—type 2 diabetes mellitus	0.000641	0.00309	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.000637	0.00307	CcSEcCtD
Latanoprost—Asthma—Irbesartan—type 2 diabetes mellitus	0.000634	0.00306	CcSEcCtD
Latanoprost—Discomfort—Sitagliptin—type 2 diabetes mellitus	0.000634	0.00306	CcSEcCtD
Latanoprost—Oedema—Pioglitazone—type 2 diabetes mellitus	0.000633	0.00305	CcSEcCtD
Latanoprost—Urinary tract infection—Orlistat—type 2 diabetes mellitus	0.000632	0.00305	CcSEcCtD
Latanoprost—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000628	0.00303	CcSEcCtD
Latanoprost—Rash—Tolazamide—type 2 diabetes mellitus	0.000628	0.00303	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Metformin—type 2 diabetes mellitus	0.000624	0.00301	CcSEcCtD
Latanoprost—Headache—Tolazamide—type 2 diabetes mellitus	0.000624	0.00301	CcSEcCtD
Latanoprost—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000624	0.00301	CcSEcCtD
Latanoprost—Erythema—Glyburide—type 2 diabetes mellitus	0.000623	0.00301	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Losartan—type 2 diabetes mellitus	0.000622	0.003	CcSEcCtD
Latanoprost—Rash—Linagliptin—type 2 diabetes mellitus	0.000622	0.003	CcSEcCtD
Latanoprost—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000621	0.003	CcSEcCtD
Latanoprost—Nervous system disorder—Pioglitazone—type 2 diabetes mellitus	0.000621	0.003	CcSEcCtD
Latanoprost—Angina pectoris—Irbesartan—type 2 diabetes mellitus	0.000618	0.00298	CcSEcCtD
Latanoprost—Headache—Linagliptin—type 2 diabetes mellitus	0.000618	0.00298	CcSEcCtD
Latanoprost—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000615	0.00297	CcSEcCtD
Latanoprost—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00061	0.00294	CcSEcCtD
Latanoprost—Rash—Acarbose—type 2 diabetes mellitus	0.000603	0.00291	CcSEcCtD
Latanoprost—Nervous system disorder—Sitagliptin—type 2 diabetes mellitus	0.000603	0.00291	CcSEcCtD
Latanoprost—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000603	0.00291	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.000602	0.0029	CcSEcCtD
Latanoprost—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.000597	0.00288	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Irbesartan—type 2 diabetes mellitus	0.000589	0.00284	CcSEcCtD
Latanoprost—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000589	0.00284	CcSEcCtD
Latanoprost—Vision blurred—Glyburide—type 2 diabetes mellitus	0.000587	0.00283	CcSEcCtD
Latanoprost—Rash—Nateglinide—type 2 diabetes mellitus	0.000582	0.00281	CcSEcCtD
Latanoprost—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000581	0.0028	CcSEcCtD
Latanoprost—Angina pectoris—Losartan—type 2 diabetes mellitus	0.000581	0.0028	CcSEcCtD
Latanoprost—Connective tissue disorder—Valsartan—type 2 diabetes mellitus	0.00058	0.0028	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.000577	0.00278	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000576	0.00278	CcSEcCtD
Latanoprost—Bronchitis—Losartan—type 2 diabetes mellitus	0.000574	0.00277	CcSEcCtD
Latanoprost—Pain—Glipizide—type 2 diabetes mellitus	0.000565	0.00273	CcSEcCtD
Latanoprost—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000565	0.00273	CcSEcCtD
Latanoprost—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.000564	0.00272	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.00056	0.0027	CcSEcCtD
Latanoprost—Erythema—Gliclazide—type 2 diabetes mellitus	0.00056	0.0027	CcSEcCtD
Latanoprost—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000556	0.00268	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.000555	0.00268	CcSEcCtD
Latanoprost—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.00055	0.00265	CcSEcCtD
Latanoprost—Conjunctivitis—Irbesartan—type 2 diabetes mellitus	0.00055	0.00265	CcSEcCtD
Latanoprost—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.00055	0.00265	CcSEcCtD
Latanoprost—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000546	0.00263	CcSEcCtD
Latanoprost—Back pain—Gliclazide—type 2 diabetes mellitus	0.000541	0.00261	CcSEcCtD
Latanoprost—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.00054	0.00261	CcSEcCtD
Latanoprost—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000534	0.00258	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000533	0.00257	CcSEcCtD
Latanoprost—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000532	0.00257	CcSEcCtD
Latanoprost—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000531	0.00256	CcSEcCtD
Latanoprost—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000529	0.00255	CcSEcCtD
Latanoprost—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000526	0.00254	CcSEcCtD
Latanoprost—Pain—Sitagliptin—type 2 diabetes mellitus	0.000526	0.00254	CcSEcCtD
Latanoprost—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.000517	0.00249	CcSEcCtD
Latanoprost—Conjunctivitis—Losartan—type 2 diabetes mellitus	0.000517	0.00249	CcSEcCtD
Latanoprost—Asthma—Ramipril—type 2 diabetes mellitus	0.000512	0.00247	CcSEcCtD
Latanoprost—Oedema—Glyburide—type 2 diabetes mellitus	0.000509	0.00245	CcSEcCtD
Latanoprost—Rash—Repaglinide—type 2 diabetes mellitus	0.000504	0.00243	CcSEcCtD
Latanoprost—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000503	0.00243	CcSEcCtD
Latanoprost—Headache—Repaglinide—type 2 diabetes mellitus	0.0005	0.00241	CcSEcCtD
Latanoprost—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000499	0.00241	CcSEcCtD
Latanoprost—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000499	0.00241	CcSEcCtD
Latanoprost—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000499	0.00241	CcSEcCtD
Latanoprost—Angina pectoris—Ramipril—type 2 diabetes mellitus	0.000498	0.0024	CcSEcCtD
Latanoprost—Back pain—Valsartan—type 2 diabetes mellitus	0.000497	0.0024	CcSEcCtD
Latanoprost—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000496	0.00239	CcSEcCtD
Latanoprost—Bronchitis—Ramipril—type 2 diabetes mellitus	0.000492	0.00237	CcSEcCtD
Latanoprost—Back pain—Orlistat—type 2 diabetes mellitus	0.000491	0.00237	CcSEcCtD
Latanoprost—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000485	0.00234	CcSEcCtD
Latanoprost—Vision blurred—Valsartan—type 2 diabetes mellitus	0.000485	0.00234	CcSEcCtD
Latanoprost—Vision blurred—Orlistat—type 2 diabetes mellitus	0.000479	0.00231	CcSEcCtD
Latanoprost—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000476	0.0023	CcSEcCtD
Latanoprost—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000476	0.0023	CcSEcCtD
Latanoprost—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000476	0.0023	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000476	0.00229	CcSEcCtD
Latanoprost—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000476	0.00229	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000473	0.00228	CcSEcCtD
Latanoprost—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000473	0.00228	CcSEcCtD
Latanoprost—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000471	0.00227	CcSEcCtD
Latanoprost—Erythema—Metformin—type 2 diabetes mellitus	0.000468	0.00226	CcSEcCtD
Latanoprost—Pruritus—Glipizide—type 2 diabetes mellitus	0.000468	0.00226	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000463	0.00224	CcSEcCtD
Latanoprost—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000457	0.00221	CcSEcCtD
Latanoprost—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000453	0.00219	CcSEcCtD
Latanoprost—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000448	0.00216	CcSEcCtD
Latanoprost—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000444	0.00214	CcSEcCtD
Latanoprost—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000443	0.00214	CcSEcCtD
Latanoprost—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000443	0.00214	CcSEcCtD
Latanoprost—Erythema—Irbesartan—type 2 diabetes mellitus	0.000442	0.00213	CcSEcCtD
Latanoprost—Vision blurred—Metformin—type 2 diabetes mellitus	0.000441	0.00213	CcSEcCtD
Latanoprost—Chest pain—Valsartan—type 2 diabetes mellitus	0.000438	0.00211	CcSEcCtD
Latanoprost—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000438	0.00211	CcSEcCtD
Latanoprost—Dizziness—Glipizide—type 2 diabetes mellitus	0.000437	0.00211	CcSEcCtD
Latanoprost—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000436	0.0021	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000435	0.0021	CcSEcCtD
Latanoprost—Chest pain—Orlistat—type 2 diabetes mellitus	0.000433	0.00209	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00043	0.00207	CcSEcCtD
Latanoprost—Discomfort—Orlistat—type 2 diabetes mellitus	0.000427	0.00206	CcSEcCtD
Latanoprost—Oedema—Valsartan—type 2 diabetes mellitus	0.00042	0.00202	CcSEcCtD
Latanoprost—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000419	0.00202	CcSEcCtD
Latanoprost—Rash—Glipizide—type 2 diabetes mellitus	0.000417	0.00201	CcSEcCtD
Latanoprost—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000416	0.00201	CcSEcCtD
Latanoprost—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000416	0.00201	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000416	0.00201	CcSEcCtD
Latanoprost—Erythema—Losartan—type 2 diabetes mellitus	0.000416	0.00201	CcSEcCtD
Latanoprost—Oedema—Orlistat—type 2 diabetes mellitus	0.000415	0.002	CcSEcCtD
Latanoprost—Headache—Glipizide—type 2 diabetes mellitus	0.000414	0.002	CcSEcCtD
Latanoprost—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000411	0.00199	CcSEcCtD
Latanoprost—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000408	0.00197	CcSEcCtD
Latanoprost—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000408	0.00197	CcSEcCtD
Latanoprost—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000407	0.00196	CcSEcCtD
Latanoprost—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000407	0.00196	CcSEcCtD
Latanoprost—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000407	0.00196	CcSEcCtD
Latanoprost—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000403	0.00194	CcSEcCtD
Latanoprost—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000402	0.00194	CcSEcCtD
Latanoprost—Back pain—Losartan—type 2 diabetes mellitus	0.000402	0.00194	CcSEcCtD
Latanoprost—Chest pain—Metformin—type 2 diabetes mellitus	0.000399	0.00192	CcSEcCtD
Latanoprost—Headache—Pioglitazone—type 2 diabetes mellitus	0.000397	0.00191	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000396	0.00191	CcSEcCtD
Latanoprost—Discomfort—Metformin—type 2 diabetes mellitus	0.000394	0.0019	CcSEcCtD
Latanoprost—Vision blurred—Losartan—type 2 diabetes mellitus	0.000392	0.00189	CcSEcCtD
Latanoprost—Pain—Gliclazide—type 2 diabetes mellitus	0.000391	0.00188	CcSEcCtD
Latanoprost—Rash—Glimepiride—type 2 diabetes mellitus	0.000389	0.00188	CcSEcCtD
Latanoprost—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000388	0.00187	CcSEcCtD
Latanoprost—Rash—Sitagliptin—type 2 diabetes mellitus	0.000388	0.00187	CcSEcCtD
Latanoprost—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000387	0.00187	CcSEcCtD
Latanoprost—Headache—Glimepiride—type 2 diabetes mellitus	0.000386	0.00186	CcSEcCtD
Latanoprost—Headache—Sitagliptin—type 2 diabetes mellitus	0.000385	0.00186	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000382	0.00184	CcSEcCtD
Latanoprost—Oedema—Metformin—type 2 diabetes mellitus	0.000382	0.00184	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000378	0.00182	CcSEcCtD
Latanoprost—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000376	0.00181	CcSEcCtD
Latanoprost—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000376	0.00181	CcSEcCtD
Latanoprost—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000375	0.00181	CcSEcCtD
Latanoprost—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000374	0.0018	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000374	0.0018	CcSEcCtD
Latanoprost—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000372	0.00179	CcSEcCtD
Latanoprost—Skin disorder—Metformin—type 2 diabetes mellitus	0.000371	0.00179	CcSEcCtD
Latanoprost—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000369	0.00178	CcSEcCtD
Latanoprost—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000368	0.00177	CcSEcCtD
Latanoprost—Oedema—Irbesartan—type 2 diabetes mellitus	0.000361	0.00174	CcSEcCtD
Latanoprost—Pruritus—Glyburide—type 2 diabetes mellitus	0.00036	0.00174	CcSEcCtD
Latanoprost—Erythema—Ramipril—type 2 diabetes mellitus	0.000357	0.00172	CcSEcCtD
Latanoprost—Pain—Orlistat—type 2 diabetes mellitus	0.000355	0.00171	CcSEcCtD
Latanoprost—Arthralgia—Losartan—type 2 diabetes mellitus	0.000354	0.00171	CcSEcCtD
Latanoprost—Chest pain—Losartan—type 2 diabetes mellitus	0.000354	0.00171	CcSEcCtD
Latanoprost—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000354	0.00171	CcSEcCtD
Latanoprost—Rash—Bromocriptine—type 2 diabetes mellitus	0.000351	0.00169	CcSEcCtD
Latanoprost—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00035	0.00169	CcSEcCtD
Latanoprost—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00035	0.00169	CcSEcCtD
Latanoprost—Discomfort—Losartan—type 2 diabetes mellitus	0.00035	0.00169	CcSEcCtD
Latanoprost—Headache—Bromocriptine—type 2 diabetes mellitus	0.000349	0.00168	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000348	0.00168	CcSEcCtD
Latanoprost—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000341	0.00164	CcSEcCtD
Latanoprost—Oedema—Losartan—type 2 diabetes mellitus	0.000339	0.00164	CcSEcCtD
Latanoprost—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000333	0.00161	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000329	0.00158	CcSEcCtD
Latanoprost—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000323	0.00156	CcSEcCtD
Latanoprost—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000321	0.00155	CcSEcCtD
Latanoprost—Rash—Glyburide—type 2 diabetes mellitus	0.000321	0.00155	CcSEcCtD
Latanoprost—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00032	0.00155	CcSEcCtD
Latanoprost—Headache—Glyburide—type 2 diabetes mellitus	0.000319	0.00154	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000309	0.00149	CcSEcCtD
Latanoprost—Pain—Irbesartan—type 2 diabetes mellitus	0.000308	0.00149	CcSEcCtD
Latanoprost—Chest pain—Ramipril—type 2 diabetes mellitus	0.000304	0.00146	CcSEcCtD
Latanoprost—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000304	0.00146	CcSEcCtD
Latanoprost—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000303	0.00146	CcSEcCtD
Latanoprost—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000302	0.00146	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000301	0.00145	CcSEcCtD
Latanoprost—Discomfort—Ramipril—type 2 diabetes mellitus	0.0003	0.00145	CcSEcCtD
Latanoprost—Pruritus—Valsartan—type 2 diabetes mellitus	0.000297	0.00143	CcSEcCtD
Latanoprost—Pruritus—Orlistat—type 2 diabetes mellitus	0.000293	0.00142	CcSEcCtD
Latanoprost—Oedema—Ramipril—type 2 diabetes mellitus	0.000291	0.0014	CcSEcCtD
Latanoprost—Pain—Losartan—type 2 diabetes mellitus	0.00029	0.0014	CcSEcCtD
Latanoprost—Rash—Gliclazide—type 2 diabetes mellitus	0.000288	0.00139	CcSEcCtD
Latanoprost—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000288	0.00139	CcSEcCtD
Latanoprost—Headache—Gliclazide—type 2 diabetes mellitus	0.000286	0.00138	CcSEcCtD
Latanoprost—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000285	0.00138	CcSEcCtD
Latanoprost—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000283	0.00136	CcSEcCtD
Latanoprost—Dizziness—Valsartan—type 2 diabetes mellitus	0.000277	0.00134	CcSEcCtD
Latanoprost—Dizziness—Orlistat—type 2 diabetes mellitus	0.000274	0.00132	CcSEcCtD
Latanoprost—Pruritus—Metformin—type 2 diabetes mellitus	0.00027	0.0013	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000265	0.00128	CcSEcCtD
Latanoprost—Rash—Valsartan—type 2 diabetes mellitus	0.000265	0.00128	CcSEcCtD
Latanoprost—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000264	0.00128	CcSEcCtD
Latanoprost—Headache—Valsartan—type 2 diabetes mellitus	0.000263	0.00127	CcSEcCtD
Latanoprost—Rash—Orlistat—type 2 diabetes mellitus	0.000261	0.00126	CcSEcCtD
Latanoprost—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000261	0.00126	CcSEcCtD
Latanoprost—Headache—Orlistat—type 2 diabetes mellitus	0.00026	0.00125	CcSEcCtD
Latanoprost—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000259	0.00125	CcSEcCtD
Latanoprost—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000255	0.00123	CcSEcCtD
Latanoprost—Dizziness—Metformin—type 2 diabetes mellitus	0.000253	0.00122	CcSEcCtD
Latanoprost—Rash—Metformin—type 2 diabetes mellitus	0.000241	0.00116	CcSEcCtD
Latanoprost—Dermatitis—Metformin—type 2 diabetes mellitus	0.000241	0.00116	CcSEcCtD
Latanoprost—Pruritus—Losartan—type 2 diabetes mellitus	0.00024	0.00116	CcSEcCtD
Latanoprost—Headache—Metformin—type 2 diabetes mellitus	0.000239	0.00115	CcSEcCtD
Latanoprost—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000238	0.00115	CcSEcCtD
Latanoprost—Rash—Irbesartan—type 2 diabetes mellitus	0.000227	0.0011	CcSEcCtD
Latanoprost—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000227	0.0011	CcSEcCtD
Latanoprost—Headache—Irbesartan—type 2 diabetes mellitus	0.000226	0.00109	CcSEcCtD
Latanoprost—Dizziness—Losartan—type 2 diabetes mellitus	0.000224	0.00108	CcSEcCtD
Latanoprost—Rash—Losartan—type 2 diabetes mellitus	0.000214	0.00103	CcSEcCtD
Latanoprost—Dermatitis—Losartan—type 2 diabetes mellitus	0.000214	0.00103	CcSEcCtD
Latanoprost—Headache—Losartan—type 2 diabetes mellitus	0.000213	0.00103	CcSEcCtD
Latanoprost—Pruritus—Ramipril—type 2 diabetes mellitus	0.000206	0.000993	CcSEcCtD
Latanoprost—Dizziness—Ramipril—type 2 diabetes mellitus	0.000192	0.000928	CcSEcCtD
Latanoprost—Rash—Ramipril—type 2 diabetes mellitus	0.000183	0.000885	CcSEcCtD
Latanoprost—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000183	0.000884	CcSEcCtD
Latanoprost—Headache—Ramipril—type 2 diabetes mellitus	0.000182	0.000879	CcSEcCtD
Latanoprost—PTGFR—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000121	0.00105	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000121	0.00105	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.00012	0.00104	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000118	0.00102	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000118	0.00102	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000117	0.00102	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000117	0.00101	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000116	0.001	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000115	0.000998	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000115	0.000998	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000115	0.000991	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.000114	0.00099	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000114	0.000986	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000113	0.000974	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000112	0.000973	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000111	0.000961	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000111	0.000961	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000111	0.000959	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GIP—type 2 diabetes mellitus	0.00011	0.000953	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000109	0.000944	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000109	0.000944	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000108	0.000938	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000108	0.000933	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000107	0.000925	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000106	0.000919	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000105	0.000909	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000105	0.000906	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	0.000105	0.000904	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000104	0.000902	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000104	0.000899	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000104	0.000895	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000103	0.000894	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000103	0.000887	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000102	0.000884	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000102	0.000882	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000101	0.000872	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.0001	0.000866	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TLE4—type 2 diabetes mellitus	9.74e-05	0.000842	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	9.66e-05	0.000836	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GCG—type 2 diabetes mellitus	9.47e-05	0.000819	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	9.44e-05	0.000817	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	9.43e-05	0.000816	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—BHMT—type 2 diabetes mellitus	9.41e-05	0.000814	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADRB3—type 2 diabetes mellitus	9.37e-05	0.000811	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	9.31e-05	0.000806	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	9.12e-05	0.000789	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CRHR1—type 2 diabetes mellitus	9.05e-05	0.000783	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—GNB3—type 2 diabetes mellitus	9.03e-05	0.000781	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	9.03e-05	0.000781	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	8.99e-05	0.000777	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AVP—type 2 diabetes mellitus	8.86e-05	0.000767	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	8.75e-05	0.000756	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.72e-05	0.000754	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	8.49e-05	0.000734	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	8.43e-05	0.000729	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	8.35e-05	0.000723	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	8.28e-05	0.000716	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SPRY2—type 2 diabetes mellitus	8.28e-05	0.000716	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AANAT—type 2 diabetes mellitus	8.23e-05	0.000711	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGDS—type 2 diabetes mellitus	8.23e-05	0.000711	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	8.18e-05	0.000707	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—GNB3—type 2 diabetes mellitus	8.16e-05	0.000706	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RBP4—type 2 diabetes mellitus	8.07e-05	0.000698	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GLP1R—type 2 diabetes mellitus	8.07e-05	0.000698	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—ADCY5—type 2 diabetes mellitus	8.05e-05	0.000697	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AVP—type 2 diabetes mellitus	8.05e-05	0.000696	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—MMP3—type 2 diabetes mellitus	8.05e-05	0.000696	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	8.03e-05	0.000695	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	8.01e-05	0.000693	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCKAR—type 2 diabetes mellitus	7.94e-05	0.000687	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CDO1—type 2 diabetes mellitus	7.8e-05	0.000674	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GPD2—type 2 diabetes mellitus	7.8e-05	0.000674	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EDN1—type 2 diabetes mellitus	7.66e-05	0.000662	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	7.59e-05	0.000657	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	7.54e-05	0.000652	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AK1—type 2 diabetes mellitus	7.44e-05	0.000643	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—C3—type 2 diabetes mellitus	7.37e-05	0.000637	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	7.27e-05	0.000629	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	7.25e-05	0.000627	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	7.25e-05	0.000627	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	7.19e-05	0.000622	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IAPP—type 2 diabetes mellitus	7.15e-05	0.000618	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—INSR—type 2 diabetes mellitus	7.1e-05	0.000614	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	7.07e-05	0.000612	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	7.03e-05	0.000608	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AGT—type 2 diabetes mellitus	7e-05	0.000605	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	6.99e-05	0.000605	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TRPC6—type 2 diabetes mellitus	6.98e-05	0.000604	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	6.97e-05	0.000603	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AGTR2—type 2 diabetes mellitus	6.94e-05	0.0006	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—CALM1—type 2 diabetes mellitus	6.92e-05	0.000598	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MAT1A—type 2 diabetes mellitus	6.86e-05	0.000594	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC5A4—type 2 diabetes mellitus	6.86e-05	0.000594	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCR5—type 2 diabetes mellitus	6.84e-05	0.000592	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—C3—type 2 diabetes mellitus	6.69e-05	0.000579	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.64e-05	0.000575	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ND1—type 2 diabetes mellitus	6.63e-05	0.000574	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	6.63e-05	0.000574	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ENPP1—type 2 diabetes mellitus	6.63e-05	0.000574	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—G6PC—type 2 diabetes mellitus	6.63e-05	0.000574	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HBA2—type 2 diabetes mellitus	6.63e-05	0.000574	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—PRKCB—type 2 diabetes mellitus	6.5e-05	0.000562	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.48e-05	0.00056	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	6.47e-05	0.000559	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HTR2C—type 2 diabetes mellitus	6.45e-05	0.000558	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PSMD6—type 2 diabetes mellitus	6.45e-05	0.000558	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GCGR—type 2 diabetes mellitus	6.42e-05	0.000555	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AGT—type 2 diabetes mellitus	6.36e-05	0.00055	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EDNRA—type 2 diabetes mellitus	6.27e-05	0.000543	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CALM1—type 2 diabetes mellitus	6.25e-05	0.000541	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CYBA—type 2 diabetes mellitus	6.25e-05	0.00054	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	6.16e-05	0.000533	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	6.14e-05	0.000531	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GHRL—type 2 diabetes mellitus	6.11e-05	0.000529	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PLAT—type 2 diabetes mellitus	6.11e-05	0.000529	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—OXCT1—type 2 diabetes mellitus	6.06e-05	0.000525	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYTB—type 2 diabetes mellitus	6.06e-05	0.000525	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CALCA—type 2 diabetes mellitus	6.04e-05	0.000522	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SRD5A1—type 2 diabetes mellitus	5.91e-05	0.000511	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	5.88e-05	0.000508	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	5.87e-05	0.000508	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	5.71e-05	0.000494	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.69e-05	0.000492	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.66e-05	0.00049	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HSD17B3—type 2 diabetes mellitus	5.64e-05	0.000488	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ACACA—type 2 diabetes mellitus	5.64e-05	0.000488	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—STAR—type 2 diabetes mellitus	5.64e-05	0.000488	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	5.64e-05	0.000487	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.59e-05	0.000484	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GCG—type 2 diabetes mellitus	5.59e-05	0.000484	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.5e-05	0.000476	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.48e-05	0.000474	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ABCC8—type 2 diabetes mellitus	5.4e-05	0.000468	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CBS—type 2 diabetes mellitus	5.4e-05	0.000468	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.23e-05	0.000453	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC5A2—type 2 diabetes mellitus	5.2e-05	0.00045	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—COX2—type 2 diabetes mellitus	5.2e-05	0.00045	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKT2—type 2 diabetes mellitus	5.14e-05	0.000445	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	5.14e-05	0.000444	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NCOA6—type 2 diabetes mellitus	5.11e-05	0.000442	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HSD11B1—type 2 diabetes mellitus	5.02e-05	0.000435	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—UCP3—type 2 diabetes mellitus	5.02e-05	0.000435	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—UCP2—type 2 diabetes mellitus	5.02e-05	0.000435	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.87e-05	0.000421	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	4.86e-05	0.00042	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	4.84e-05	0.000418	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.82e-05	0.000417	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	4.79e-05	0.000414	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.76e-05	0.000411	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AVP—type 2 diabetes mellitus	4.76e-05	0.000411	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.73e-05	0.00041	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PCK1—type 2 diabetes mellitus	4.72e-05	0.000409	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.71e-05	0.000408	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.66e-05	0.000404	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	4.63e-05	0.000401	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOB—type 2 diabetes mellitus	4.6e-05	0.000398	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.58e-05	0.000396	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.52e-05	0.000391	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HK1—type 2 diabetes mellitus	4.42e-05	0.000383	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LPL—type 2 diabetes mellitus	4.39e-05	0.00038	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	4.33e-05	0.000374	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.3e-05	0.000372	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HSD3B2—type 2 diabetes mellitus	4.27e-05	0.00037	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LPA—type 2 diabetes mellitus	4.27e-05	0.00037	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GCKR—type 2 diabetes mellitus	4.27e-05	0.00037	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—KCNJ11—type 2 diabetes mellitus	4.27e-05	0.00037	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.12e-05	0.000356	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALDOB—type 2 diabetes mellitus	4.1e-05	0.000354	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.04e-05	0.00035	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—C3—type 2 diabetes mellitus	3.95e-05	0.000342	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	3.91e-05	0.000338	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GLP1R—type 2 diabetes mellitus	3.81e-05	0.000329	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.77e-05	0.000326	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.76e-05	0.000325	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AGT—type 2 diabetes mellitus	3.75e-05	0.000325	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.69e-05	0.000319	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOE—type 2 diabetes mellitus	3.68e-05	0.000318	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LEP—type 2 diabetes mellitus	3.68e-05	0.000318	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	3.66e-05	0.000317	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.64e-05	0.000315	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC2A2—type 2 diabetes mellitus	3.56e-05	0.000308	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTR—type 2 diabetes mellitus	3.48e-05	0.000301	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CPT1A—type 2 diabetes mellitus	3.48e-05	0.000301	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.47e-05	0.0003	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NAMPT—type 2 diabetes mellitus	3.42e-05	0.000295	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LIPC—type 2 diabetes mellitus	3.39e-05	0.000294	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HBA1—type 2 diabetes mellitus	3.39e-05	0.000294	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GCK—type 2 diabetes mellitus	3.39e-05	0.000294	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP11A1—type 2 diabetes mellitus	3.37e-05	0.000292	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC9A1—type 2 diabetes mellitus	3.31e-05	0.000287	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.28e-05	0.000284	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CETP—type 2 diabetes mellitus	3.27e-05	0.000283	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—INS—type 2 diabetes mellitus	3.14e-05	0.000272	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.09e-05	0.000267	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SNAP25—type 2 diabetes mellitus	3.04e-05	0.000263	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PSMD6—type 2 diabetes mellitus	3.04e-05	0.000263	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SREBF1—type 2 diabetes mellitus	3.04e-05	0.000263	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.04e-05	0.000263	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.04e-05	0.000263	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.02e-05	0.000262	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CTGF—type 2 diabetes mellitus	2.99e-05	0.000258	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HMGCR—type 2 diabetes mellitus	2.96e-05	0.000256	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.9e-05	0.000251	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.9e-05	0.000251	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.89e-05	0.00025	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP2E1—type 2 diabetes mellitus	2.78e-05	0.000241	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.76e-05	0.000238	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.76e-05	0.000238	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP1A2—type 2 diabetes mellitus	2.75e-05	0.000238	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC2A1—type 2 diabetes mellitus	2.75e-05	0.000238	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.68e-05	0.000232	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GCG—type 2 diabetes mellitus	2.64e-05	0.000228	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.64e-05	0.000228	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RELA—type 2 diabetes mellitus	2.59e-05	0.000224	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.36e-05	0.000204	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.34e-05	0.000202	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.32e-05	0.000201	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	2.27e-05	0.000197	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.27e-05	0.000197	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	2.26e-05	0.000196	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	2.23e-05	0.000193	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.21e-05	0.000191	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.19e-05	0.000189	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	2.17e-05	0.000188	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.14e-05	0.000185	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	2.11e-05	0.000183	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	2.07e-05	0.000179	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SRC—type 2 diabetes mellitus	2.04e-05	0.000176	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.03e-05	0.000175	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	2.02e-05	0.000175	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.99e-05	0.000172	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	1.97e-05	0.00017	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.94e-05	0.000168	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.86e-05	0.000161	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	1.83e-05	0.000158	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.82e-05	0.000158	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.79e-05	0.000155	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	1.77e-05	0.000153	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	1.74e-05	0.000151	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	1.74e-05	0.00015	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	1.72e-05	0.000148	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	1.51e-05	0.000131	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	1.48e-05	0.000128	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6—type 2 diabetes mellitus	1.37e-05	0.000119	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	1.36e-05	0.000118	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.3e-05	0.000113	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	1.3e-05	0.000113	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.27e-05	0.00011	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.19e-05	0.000103	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	5.98e-06	5.17e-05	CbGpPWpGaD
